releases

Vanderbilt awarded $4.4 million by the Michael J. Fox Foundation; Goal is to develop new class of Parkinson’s disease drugs

A drug discovery team at Vanderbilt University Medical Center led by Jeffrey Conn has been awarded a $4.4 million “LEAPS” grant by the Michael J. Fox Foundation for Parkinson’s Research to jump-start development of a new class of Parkinson’s diseasedrugs.

RNA therapy heals growth deficiency disorder in a live animal

A team of Vanderbilt researchers has demonstrated for the first time that a new type of gene therapy, called RNA interference, can heal a genetic disorder in a live animal.

Vanderbilt Announces Opening of New Primary Practice in Westhaven

Vanderbilt Medical Group Westhaven is pleased to announce the opening of a new Primary Care Practice. The new practice, opening Jan. 2, 2008, is located off Highway 96, at1025 Westhaven Blvd, Franklin, Tenn., in the Westhaven Community.

Tennessee Poison Control Center offers holiday safety advice; Keep a watchful eye for unsafe toys and potentially dangerous poisonous plants

Poisonous plants, holiday decorations and unsafe toys are just a few of the potential hazards children face during the holidays.

Vanderbilt doctors warn against “Merry Christmas Coronary”

Some studies indicate that death rates from heart attacks and stroke as well as non-heart-related causes spike during the holiday season. Researchers have coined this phenomenon "Merry Christmas Coronary and Happy New Year Heart Attack."

Vanderbilt study links melatonin excretion with sleep levels in children with autism; Children with deeper levels of sleep have higher levels of melatonin

Vanderbilt sleep researchers are reporting a relationship between good sleep and how much melatonin the body produces ñ the first in a series of research studies intended to help children with autism spectrum disorders sleep through the night.

1 37 38 39 40 41 63